β-endorphin tolerance is inhibited by oxytocin

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The repeated administration of β-endorphin to mice resulted in the development of tolerance to the analgesic effect of the opioid peptide. While SC injections of oxytocin failed to modify the magnitude or the duration of the analgesic effect of a single intracerebroventricular (ICV) β-endorphin injection, the development of tolerance to β-endorphin was antagonized by SC and ICV oxytocin treatment. Since both oxytocin and β-endorphin are endogenous peptides in the brain, the data raise the possibility that endogenous oxytocin might be involved in the sensitivity of the central nervous system towards repeated or prolonged opioid stimulation.

Original languageEnglish
Pages (from-to)57-60
Number of pages4
JournalPharmacology, Biochemistry and Behavior
Volume26
Issue number1
DOIs
Publication statusPublished - 1987

Fingerprint

Endorphins
Oxytocin
Analgesics
Injections
Opioid Peptides
Neurology
Opioid Analgesics
Brain
Central Nervous System
Peptides

Keywords

  • Analgesic effect
  • Oxytocin
  • Tolerance
  • β-Endorphin

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

β-endorphin tolerance is inhibited by oxytocin. / Kovács, G.; Telegdy, G.

In: Pharmacology, Biochemistry and Behavior, Vol. 26, No. 1, 1987, p. 57-60.

Research output: Contribution to journalArticle

@article{580233df28754422abd69e858bf5aa75,
title = "β-endorphin tolerance is inhibited by oxytocin",
abstract = "The repeated administration of β-endorphin to mice resulted in the development of tolerance to the analgesic effect of the opioid peptide. While SC injections of oxytocin failed to modify the magnitude or the duration of the analgesic effect of a single intracerebroventricular (ICV) β-endorphin injection, the development of tolerance to β-endorphin was antagonized by SC and ICV oxytocin treatment. Since both oxytocin and β-endorphin are endogenous peptides in the brain, the data raise the possibility that endogenous oxytocin might be involved in the sensitivity of the central nervous system towards repeated or prolonged opioid stimulation.",
keywords = "Analgesic effect, Oxytocin, Tolerance, β-Endorphin",
author = "G. Kov{\'a}cs and G. Telegdy",
year = "1987",
doi = "10.1016/0091-3057(87)90533-8",
language = "English",
volume = "26",
pages = "57--60",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - β-endorphin tolerance is inhibited by oxytocin

AU - Kovács, G.

AU - Telegdy, G.

PY - 1987

Y1 - 1987

N2 - The repeated administration of β-endorphin to mice resulted in the development of tolerance to the analgesic effect of the opioid peptide. While SC injections of oxytocin failed to modify the magnitude or the duration of the analgesic effect of a single intracerebroventricular (ICV) β-endorphin injection, the development of tolerance to β-endorphin was antagonized by SC and ICV oxytocin treatment. Since both oxytocin and β-endorphin are endogenous peptides in the brain, the data raise the possibility that endogenous oxytocin might be involved in the sensitivity of the central nervous system towards repeated or prolonged opioid stimulation.

AB - The repeated administration of β-endorphin to mice resulted in the development of tolerance to the analgesic effect of the opioid peptide. While SC injections of oxytocin failed to modify the magnitude or the duration of the analgesic effect of a single intracerebroventricular (ICV) β-endorphin injection, the development of tolerance to β-endorphin was antagonized by SC and ICV oxytocin treatment. Since both oxytocin and β-endorphin are endogenous peptides in the brain, the data raise the possibility that endogenous oxytocin might be involved in the sensitivity of the central nervous system towards repeated or prolonged opioid stimulation.

KW - Analgesic effect

KW - Oxytocin

KW - Tolerance

KW - β-Endorphin

UR - http://www.scopus.com/inward/record.url?scp=0023502679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023502679&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(87)90533-8

DO - 10.1016/0091-3057(87)90533-8

M3 - Article

C2 - 2951744

AN - SCOPUS:0023502679

VL - 26

SP - 57

EP - 60

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 1

ER -